Artialis: Passion for Healthy Aging
Artialis, a leading Contract Research Development Organization (CRDO), specializes in musculoskeletal health. Offering a comprehensive range of services from preclinical research to post-marketing surveillance.
Founded in 2010, Artialis emerged from the University of Liege’s Bone and Cartilage Research Unit. With a strong foundation in scientific research, Artialis has grown into a trusted partner for pharmaceutical and biotech companies worldwide.
Over the past 14 years, Artialis has successfully completed 142 R&D projects, leveraging the combined expertise of its team, which boasts over 75 years of experience in the industry. This wealth of knowledge allows Artialis to provide tailored solutions and navigate the complexities of product development.
Driven by a commitment to client satisfaction, the company has achieved a remarkable 90% satisfaction rate.
Lear more: www.artialis.com
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
January 29, 2026
Medtech Dive Amid a deregulatory push by the Trump administration, the Food and Drug Administration is scrutinizing its digital health policies. The agency suddenly issued a pair of guidances earlier this month, intended to clarify its approach to wellness devices and medical software. The updates reflect changes to the agency’s thinking about what counts as a wellness […]
January 29, 2026
Med City News The Covid-19 pandemic impacted virtually every industry, with healthcare arguably undergoing the most drastic transformation. Pre-pandemic, most of us never could’ve imagined routine doctor visits happening over telehealth, or a brand-new vaccine being developed, tested, and authorized for emergency use in under a year. The urgency of the pandemic forced medical scientists […]
January 29, 2026
Med City News Digital databases for clinical trial searches have already changed healthcare accessibility, bringing critical information about clinical trials to the patients who need it – and to the physicians who care for them. But these databases are also enormous – alone has details of close to 500,000 studies. As a result, information about […]